Skip to main content

US ClosedU.S. Closed

TSHA: Taysha Gene Therapies, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors.

52W Range

67thpctl

Volume

0.68×avg

Market Cap

1.85BUSD

P/E Ratio

-13.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Taysha Gene Therapies, Inc.

TSHANASDAQ Global Select·USD·Closed

Taysha Gene Therapies, Inc.

TSHANASDAQ·USD·Closed

$5.77

−3.19%

$5.77

−$0.19 (3.19%)

52W Range

67thpctl

Volume

0.68×avg

Mkt Cap

1.85BUSD

P/E

-13.7TTM

Div Yield

–ann